Relmada Therapeutics, Inc. (RLMD)

3.98 +0.17 (+4.46%) USD  |  NASDAQ  |  Jan 22, 14:40
More

Relmada Therapeutics Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade